Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Funding for Oxford spinouts jumped more than three-fold year-on-year in terms, while OUI generated four new spinouts on top of 118 disclosures and 19 patents.

The Alexandria Real Estate Equities-backed regenerative medicine developer increased its total funding to $147m with a round led by Perceptive Advisors.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

While slightly less than the 16 generated by UC Davis past year, the university remains pleased with the performance of internal tech transfer operations.

Dental care network Dentolo has been picked up by insurance firm Zurich roughly two years after raising $3.5m from investors including Axel Springer Plug and Play Accelerator.

Novartis, Johnson & Johnson, Verily and GSK have all returned for Medicxi’s latest fund that brought the firm’s total assets under management to more than $1bn.

GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.

Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.

Mirum Pharmaceuticals has raised $75m in its initial public offering that had an initial target of $86.3m and provided exits to Novo and Shire.